These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 31356090

  • 1. Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model.
    Bressand D, Novell A, Girault A, Raoul W, Fromont-Hankard G, Escoffre JM, Lecomte T, Bouakaz A.
    Mol Pharm; 2019 Sep 03; 16(9):3814-3822. PubMed ID: 31356090
    [Abstract] [Full Text] [Related]

  • 2. Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcinoma.
    Kotopoulis S, Stigen E, Popa M, Safont MM, Healey A, Kvåle S, Sontum P, Gjertsen BT, Gilja OH, McCormack E.
    J Control Release; 2017 Jan 10; 245():70-80. PubMed ID: 27871988
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
    Logan KA, Nesbitt H, Callan B, Gao J, McKaig T, Taylor M, Love M, McHale AP, Callan JF.
    Eur J Pharm Biopharm; 2021 Aug 10; 165():374-382. PubMed ID: 34038797
    [Abstract] [Full Text] [Related]

  • 4. Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models.
    Awasthi N, Scire E, Monahan S, Grojean M, Zhang E, Schwarz MA, Schwarz RE.
    Oncotarget; 2016 Jul 26; 7(30):46988-47001. PubMed ID: 27127884
    [Abstract] [Full Text] [Related]

  • 5. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration.
    Chen N, Brachmann C, Liu X, Pierce DW, Dey J, Kerwin WS, Li Y, Zhou S, Hou S, Carleton M, Klinghoffer RA, Palmisano M, Chopra R.
    Cancer Chemother Pharmacol; 2015 Oct 26; 76(4):699-712. PubMed ID: 26231955
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model.
    Suenaga M, Yamada S, Fujii T, Tanaka C, Kanda M, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.
    J Surg Oncol; 2016 Mar 26; 113(4):413-9. PubMed ID: 27100026
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic Ultrasound Contrast Agents for the Enhancement of Tumor Diagnosis and Tumor Therapy.
    Moon H, Yoon C, Lee TW, Ha KS, Chang JH, Song TK, Kim K, Kim H.
    J Biomed Nanotechnol; 2015 Jul 26; 11(7):1183-92. PubMed ID: 26307841
    [Abstract] [Full Text] [Related]

  • 15. Radiation-guided drug delivery to mouse models of lung cancer.
    Hariri G, Yan H, Wang H, Han Z, Hallahan DE.
    Clin Cancer Res; 2010 Oct 15; 16(20):4968-77. PubMed ID: 20802016
    [Abstract] [Full Text] [Related]

  • 16. Ultrasound contrast-enhanced imaging and in vitro antitumor effect of paclitaxel-poly(lactic-co-glycolic acid)-monomethoxypoly (ethylene glycol) nanocapsules with ultrasound-targeted microbubble destruction.
    Ma J, Xing LX, Shen M, Li F, Zhu MJ, Jin LF, Li Z, Gao F, Su Y, Duan YR, Du LF.
    Mol Med Rep; 2015 Apr 15; 11(4):2413-20. PubMed ID: 25500683
    [Abstract] [Full Text] [Related]

  • 17. Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines.
    Braun LM, Lagies S, Guenzle J, Fichtner-Feigl S, Wittel UA, Kammerer B.
    Cells; 2020 May 19; 9(5):. PubMed ID: 32438599
    [Abstract] [Full Text] [Related]

  • 18. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
    Ma J, Shen M, Xu CS, Sun Y, Duan YR, Du LF.
    Oncotarget; 2016 Nov 29; 7(48):80008-80018. PubMed ID: 27835907
    [Abstract] [Full Text] [Related]

  • 19. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
    Shen Y, Pi Z, Yan F, Yeh CK, Zeng X, Diao X, Hu Y, Chen S, Chen X, Zheng H.
    Int J Nanomedicine; 2017 Nov 29; 12():5613-5629. PubMed ID: 28848341
    [Abstract] [Full Text] [Related]

  • 20. The winning formulation: the development of paclitaxel in pancreatic cancer.
    Ma WW, Hidalgo M.
    Clin Cancer Res; 2013 Oct 15; 19(20):5572-9. PubMed ID: 23918602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.